Yahoo
    HKSE - Delayed Quote HKD

    Clover Biopharmaceuticals, Ltd. (2197.HK)

    1.250 -0.040 (-3.10%)
    As of October 30 at 4:08:06 PM GMT+8. Market Open.
    Loading Chart for 2197.HK
    Chart Range Bar
    Interval:
    In partnership with ChartIQ

    Recent News

    Clover Announces Positive Phase 2 Clinical Data for RSV + hMPV ± PIV3 Respiratory Combination Vaccine Candidates in Older Adults

    Clover Announces Positive Phase 2 Clinical Data for RSV + hMPV ± PIV3 Respiratory Combination Vaccine Candidates in Older Adults
    PR Newswire 1mo ago
    Clover Announces Additional Positive U.S. Phase I Clinical Data for RSV Re-Vaccination in Older Adults

    Clover Announces Additional Positive U.S. Phase I Clinical Data for RSV Re-Vaccination in Older Adults
    PR Newswire 7mo ago
    Lisata adds biopharma finance veteran Jeffrey Farrow to board

    Lisata adds biopharma finance veteran Jeffrey Farrow to board
    Proactive 17d ago
    Clover Initiates Phase 2 Clinical Trial for RSV + hMPV ± PIV3 Respiratory Combination Vaccine Candidates

    Clover Initiates Phase 2 Clinical Trial for RSV + hMPV ± PIV3 Respiratory Combination Vaccine Candidates
    PR Newswire 9mo ago

    Related Tickers

    Mobilize your Website
    View Site in Mobile | Classic
    Share by: